Province clustering based on the percentage of communicable disease using the BCBimax biclustering algorithm.


Journal

Geospatial health
ISSN: 1970-7096
Titre abrégé: Geospat Health
Pays: Italy
ID NLM: 101302943

Informations de publication

Date de publication:
12 09 2023
Historique:
received: 28 03 2023
accepted: 09 08 2023
medline: 13 9 2023
pubmed: 12 9 2023
entrez: 12 9 2023
Statut: epublish

Résumé

Indonesia needs to lower its high infectious disease rate. This requires reliable data and following their temporal changes across provinces. We investigated the benefits of surveying the epidemiological situation with the imax biclustering algorithm using secondary data from a recent national scale survey of main infectious diseases from the National Basic Health Research (Riskesdas) covering 34 provinces in Indonesia. Hierarchical and k-means clustering can only handle one data source, but BCBimax biclustering can cluster rows and columns in a data matrix. Several experiments determined the best row and column threshold values, which is crucial for a useful result. The percentages of Indonesia's seven most common infectious diseases (ARI, pneumonia, diarrhoea, tuberculosis (TB), hepatitis, malaria, and filariasis) were ordered by province to form groups without considering proximity because clusters are usually far apart. ARI, pneumonia, and diarrhoea were divided into toddler and adult infections, making 10 target diseases instead of seven. The set of biclusters formed based on the presence and level of these diseases included 7 diseases with moderate to high disease levels, 5 diseases (formed by 2 clusters), 3 diseases, 2 diseases, and a final order that only included adult diarrhoea. In 6 of 8 clusters, diarrhea was the most prevalent infectious disease in Indonesia, making its eradication a priority. Direct person-to-person infections like ARI, pneumonia, TB, and diarrhoea were found in 4-6 of 8 clusters. These diseases are more common and spread faster than vector-borne diseases like malaria and filariasis, making them more important.

Identifiants

pubmed: 37698368
doi: 10.4081/gh.2023.1202
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Muhammad Nur Aidi (MN)

IPB Bogor University, Bogor. muhammadai@apps.ipb.ac.id.

Cynthia Wulandari (C)

IPB Bogor University, Bogor. cynthiawulandari46@gmail.com.

Sachnaz Desta Oktarina (SD)

IPB Bogor University, Bogor. sachnazdes@apps.ipb.ac.id.

Taufiqur Rakhim Aditra (TR)

Airlangga University, Surabaya. taufiqur_rakhim@yahoo.com.

Fitrah Ernawati (F)

National Research and Innovation Agency, Jakarta. fitr043@brin.go.id.

Efriwati Efriwati (E)

National Research and Innovation Agency, Jakarta. efri003@brin.go.id.

Nunung Nurjanah (N)

National Research and Innovation Agency, Jakarta. nunu006@brin.go.id.

Rika Rachmawati (R)

National Research and Innovation Agency, Jakarta. rika016@brin.go.id.

Elisa Diana Julianti (ED)

National Research and Innovation Agency, Jakarta. elis007@brin.go.id.

Dian Sundari (D)

National Research and Innovation Agency, Jakarta. dian079@brin.go.id.

Fifi Retiaty (F)

National Research and Innovation Agency, Jakarta. fifi007@brin.go.id.

Aya Yuriestia Arifin (AY)

National Research and Innovation Agency, Jakarta. ayay001@brin.go.id.

Rita Marleta Dewi (RM)

National Research and Innovation Agency, Jakarta. rita010@brin.go.id.

Nazarina Nazaruddin (N)

National Research and Innovation Agency, Jakarta. naza003@brin.go.id.

Salimar Salimar (S)

National Research and Innovation Agency, Jakarta. sali005@brin.go.id.

Noviati Fuada (N)

National Research and Innovation Agency, Jakarta. novifuada@gmail.com.

Yekti Widodo (Y)

National Research and Innovation Agency, Jakarta. widodoyekti67@gmail.com.

Budi Setyawati (B)

National Research and Innovation Agency, Jakarta. budi.setyawati.ipb@gmail.com.

Nuzuliyati Nurhidayati (N)

National Research and Innovation Agency, Jakarta. nuzuliyati@yahoo.com.

Sudikno Sudikno (S)

National Research and Innovation Agency, Jakarta. sudikno@brin.go.id.

Irlina Raswanti Irawan (IR)

National Research and Innovation Agency, Jakarta. irli001@brin.go.id.

Widoretno Widoretno (W)

National Research and Innovation Agency, Jakarta. wido009@brin.go.id.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH